X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (76) 76
humans (65) 65
female (52) 52
male (49) 49
middle aged (49) 49
adult (40) 40
aged (33) 33
hematology (24) 24
treatment outcome (21) 21
primary health care (17) 17
primary care (15) 15
macrophages (13) 13
analysis (12) 12
oncology (12) 12
medicine, general & internal (11) 11
prognosis (11) 11
adolescent (10) 10
cost-benefit analysis (10) 10
depression (10) 10
follow-up studies (10) 10
immunology (10) 10
management (10) 10
psychiatry (10) 10
quality of life (10) 10
spain (10) 10
young adult (10) 10
antidepressants (9) 9
clinical neurology (9) 9
cytokines (9) 9
depression, mental (9) 9
fibromyalgia (9) 9
metaanalysis (9) 9
surveys and questionnaires (9) 9
adherence (8) 8
animals (8) 8
care and treatment (8) 8
clinical trials (8) 8
efficacy (8) 8
inflammation (8) 8
medication adherence (8) 8
prevalence (8) 8
aged, 80 and over (7) 7
antidepressant treatment (7) 7
chemotherapy (7) 7
cirrhosis (7) 7
disorders (7) 7
leukemia (7) 7
retrospective studies (7) 7
risk factors (7) 7
antidepressive agents - therapeutic use (6) 6
cancer (6) 6
cell biology (6) 6
medicine (6) 6
outcomes (6) 6
pharmacology & pharmacy (6) 6
phosphorylation (6) 6
prospective studies (6) 6
research article (6) 6
spain - epidemiology (6) 6
spanish version (6) 6
validation (6) 6
activation (5) 5
antidepressive agents (5) 5
biochemistry & molecular biology (5) 5
cost-effectiveness (5) 5
cytogenetics (5) 5
depression - drug therapy (5) 5
depressive disorder (5) 5
fibromyalgia - therapy (5) 5
hl-60 cells (5) 5
impact questionnaire (5) 5
liver cirrhosis - immunology (5) 5
medical research (5) 5
mental-disorders (5) 5
mice (5) 5
multidisciplinary sciences (5) 5
patients (5) 5
population (5) 5
quality-of-life (5) 5
risk (5) 5
science (5) 5
serotonin reuptake inhibitors (5) 5
severity (5) 5
utility (5) 5
acute promyelocytic leukemia (4) 4
adults (4) 4
age factors (4) 4
anesthesiology (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
ascites (4) 4
ascitic fluid (4) 4
big data (4) 4
blood (4) 4
candida albicans - immunology (4) 4
cell line (4) 4
cells (4) 4
chronic disease (4) 4
combined modality therapy (4) 4
cost effectiveness (4) 4
cost-utility (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2010, Volume 28, Issue 24, pp. 3872 - 3879
Journal Article
Blood, ISSN 0006-4971, 2009, Volume 114, Issue 1, pp. 148 - 152
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 05/2017, Volume 58, Issue 5, pp. 1144 - 1152
Prognostic factors in Hodgkin lymphoma (HL) still fail to accurately identify high-risk patients. Tumor microenvironment in HL is a current focus of research... 
T-cell mediated immunity | Lymphoma and Hodgkin disease | lymphocytes | FDG-PET | MACROPHAGES | PROGNOSTIC SCORE | CLASSIFICATION | INDUCTION | CHEMOTHERAPY | MICROENVIRONMENT | ONCOLOGY | DISEASE | FLOW-CYTOMETRY | SELECTION | HEMATOLOGY | T-Lymphocyte Subsets - immunology | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Lymph Nodes - pathology | Prognosis | Dacarbazine - therapeutic use | Hodgkin Disease - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Young Adult | CD4-CD8 Ratio | Bleomycin - therapeutic use | Vinblastine - adverse effects | Aged, 80 and over | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Child | Kaplan-Meier Estimate | Lymph Nodes - metabolism | Immunophenotyping | Treatment Outcome | Bleomycin - adverse effects | Lymph Nodes - immunology | Phenotype | T-Lymphocyte Subsets - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | T-Lymphocyte Subsets - metabolism | Adolescent | Biomarkers | Lymphocyte Count | Hodgkin Disease - immunology | ROC Curve | Aged | Neoplasm Staging | Doxorubicin - adverse effects | Lymphocytes, Tumor-Infiltrating - immunology | Index Medicus
Journal Article
Leukemia Research, ISSN 0145-2126, 2009, Volume 33, Issue 12, pp. 1706 - 1709
Journal Article
European Journal of Haematology, ISSN 0902-4441, 07/2012, Volume 89, Issue 1, pp. 37 - 41
Objectives The myeloproliferative neoplasms displaying a PDGFRB rearrangement are rare diseases derived from a haematopoietic stem cell. The goals of the study... 
myeloproliferative neoplasms | PDGFRB | MPN | aCML | cytogenetics | in situ | atypical CML | fluorescence | CMML | FISH | chronic myelomonocytic leukaemia | hybridisation | rearrangement | Myeloproliferative neoplasms (MPNs) | PDGFRB rearrangement | Cytogenetics | Fluorescence in situ hybridisation (FISH) | Chronic myelomonocytic leukaemia (CMML) | Atypical CML (aCML) | TRANSLOCATIONS | fluorescence in situ hybridisation (FISH) | DISORDERS | CLASSIFICATION | chronic myelomonocytic leukaemia (CMML) | CHRONIC MYELOID-LEUKEMIA | BETA | GROWTH-FACTOR RECEPTOR | atypical CML (aCML) | DISEASES | myeloproliferative neoplasms (MPNs) | TARGETS | HEMATOLOGY | FUSION GENES | IMATINIB MESYLATE | Piperazines - administration & dosage | Translocation, Genetic | Follow-Up Studies | Humans | Middle Aged | Bone Marrow Neoplasms - epidemiology | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Bone Marrow Neoplasms - genetics | Receptor, Platelet-Derived Growth Factor beta - genetics | Myeloproliferative Disorders - genetics | Incidence | Aged, 80 and over | Myeloproliferative Disorders - epidemiology | Adult | Female | Pyrimidines - administration & dosage | In Situ Hybridization, Fluorescence | Treatment Outcome | Myeloproliferative Disorders - drug therapy | Piperazines - therapeutic use | Imatinib Mesylate | Protein Kinase Inhibitors - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Aged | Bone Marrow Neoplasms - drug therapy | Benzamides | Index Medicus
Journal Article
Revista Española de Cardiología, ISSN 0300-8932, 2004, Volume 57, Issue 3, pp. 201 - 208
Trabajos experimentales y clínicos sugieren que el tejido necrótico tiene la capacidad de regenerarse. Nuestro grupo ha comenzado un estudio clínico para... 
Acute myocardial infarction | Remodeling | Infarto agudo de miocardio | Remodelado | Células madre | Stem cells
Journal Article
European Journal of Haematology, ISSN 0902-4441, 11/2014, Volume 93, Issue 5, pp. 422 - 428
Journal Article
Leukemia Research, ISSN 0145-2126, 06/2009, Volume 33, Issue 6, pp. e8 - e9
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 2009, Volume 50, Issue 8, pp. 1283 - 1289
The employment of current treatments based on chemotherapy and immunotherapy leads to inmunosuppression. The presence of mutations or polymorphisms in genes... 
MBL-2 mutations | infection | follicular lymphoma | chemotherapy | rituximab | MULTIPLE-MYELOMA | MITOXANTRONE | MANNOSE-BINDING LECTIN | RESPONSE RATES | GENE POLYMORPHISMS | DEFICIENCY | SERINE PROTEASE-2 | ONCOLOGY | CHRONIC LYMPHOCYTIC-LEUKEMIA | NON-HODGKINS-LYMPHOMA | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Cyclophosphamide - administration & dosage | Lymphoma, Follicular - drug therapy | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Risk | Cyclophosphamide - adverse effects | Mannose-Binding Lectin - genetics | Infection - etiology | Genetic Variation | Neutropenia - complications | Young Adult | Early Termination of Clinical Trials | Haplotypes - genetics | Lymphoma, Follicular - epidemiology | Infection - epidemiology | Lymphoma, Follicular - genetics | Multicenter Studies as Topic | Clinical Trials, Phase II as Topic - statistics & numerical data | Adult | Female | Neutropenia - chemically induced | Genetic Predisposition to Disease | Antibodies, Monoclonal, Murine-Derived | Gene Frequency | Vidarabine - adverse effects | Anti-Infective Agents - therapeutic use | Rituximab | Vidarabine - analogs & derivatives | Lymphopenia - complications | Infection - genetics | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Spain - epidemiology | Alleles | Aged | Vidarabine - administration & dosage | Lymphopenia - chemically induced | Index Medicus
Journal Article
Revista Española de Cardiología (English Edition), ISSN 1885-5857, 2004, Volume 57, Issue 3, pp. 201 - 208
Experimental and clinical studies suggest that necrotic myocardium may have the capacity to regenerate. We have started a clinical study to demonstrate that... 
Acute myocardial infarction | Remodeling | Infarto agudo de miocardio | Remodelado | Células madre | Stem cells
Journal Article